Combination of everolimus and tacrolimus: a potentially effective regimen for recalcitrant psoriasis

Severe forms of psoriasis that are refractory to conventional therapies are often difficult to manage. The mammalian target of rapamycin (mTOR) inhibitors potentially have versatile effects toward putative psoriatic pathologic pathways. Therefore, mTOR inhibitors may offer a range of new therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Kai-Che, Lai, Ping-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Therapeutic Hotline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309507/
https://www.ncbi.nlm.nih.gov/pubmed/25285355
http://dx.doi.org/10.1111/dth.12176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309507/
https://www.ncbi.nlm.nih.gov/pubmed/25285355
http://dx.doi.org/10.1111/dth.12176

Ejemplares similares